Rapid opioid detoxification under anaesthesia

Hospital Medicine

Volumn 59, Issue 3, 1998, Pages 245-247

  Cook, T M ^a   Collins, P D ^b  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; GASTROINTESTINAL AGENT; HYPNOTIC SEDATIVE AGENT; MIDAZOLAM; NALOXONE; NALTREXONE; NARCOTIC ANTAGONIST; NICOTINIC RECEPTOR BLOCKING AGENT; OCTREOTIDE; PROPOFOL;

ADULT; ARTICLE; CASE REPORT; DRUG COMBINATION; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MALE; OPIATE ADDICTION;

ADULT; ANESTHESIA, GENERAL; ATRACURIUM; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NICOTINIC ANTAGONISTS; OCTREOTIDE; OPIOID-RELATED DISORDERS; PROPOFOL;

EID: 0032018059     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Brewer C (1997) Ultra-rapid antagonist-precipitated opiate detoxification under general anaesthesia or sedation. Addiction Biology 2: 291-302
2. Brewer C, Laban M, Schmulian C, Kasvikis Y, Maksoud NA (1997) Rapid opiate detoxification and naltrexone induction under general anaesthesia and assisted ventilation. Acta Bulletino Per le Farmacodipendenze e L'alcoolismo: 29-33
3. Gold M, Redmond DE, Kleber HD (1978) Clonidine blocks acute opiate withdrawal symptoms. Lancet ii: 599-602
4. Gooberman L, Brewer C, Maksoud N (1997) Depot-naltrexone implants for opiate dependence: clinical experience, plasma levels and opiate challenge results in over 200 patients. International Council on Alcoholism and Addictions conference. May 17-22
5. Gossop M (1988) The detoxification of high dose heroin addicts in Pakistan. Drug Alcohol Depend 24: 143-50
6. Gossop M, Strang J (1997) Rapid anaesthetic-antagonist detoxification of heroin addicts: what origins, evidence base and clinical justification? Br J Intern Care 7: 66-9
7. Kosten T, Jacobsen L, Kosten T (1989) Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Am J Drug Alcohol Abuse 15: 237-50
8. Loimer N, Schmid R, Presslich O, Lenz K (1988) Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 23: 81-6
9. Loimer N, Schmid R, Lenz K, Presslich O, Grunberger J (1990) Acute blocking of naloxonc-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 157: 748-52
10. Loimer N, Hoffman P, Chaudhry H (1993) Ultrashort noninvasive opiatc detoxification. Am J Psychiatry 150: 839
11. Mayor S (1997) Specialists criticise treatment for heroin addiction. Br Med J 314: 1365
12. Resnick RB, Kestenbaum RS, Washton A, Poole D (1977) Naloxone precipitated withdrawal: a method for rapid induction onto naltrexone. Clin Pharmacol Therapeutics 21: 409-13
13. Shufman EN, Porat S, Witzmun E, Bar-Hamburger R, Gandacu D (1994) The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biol Psychiatry 35: 935-45
14. Tornabene VW (1974) Narcotic withdrawal syndrome caused by naltrexone. Ann Intern Med 81: 785-7